FLESHER GREGORY J. 4
4 · Novus Therapeutics, Inc. · Filed Mar 20, 2020
Insider Transaction Report
Form 4
FLESHER GREGORY J.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-03-19+200,000→ 200,000 totalExercise: $0.26Exp: 2030-03-19→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 200,000 shares of the Issuer's Common Stock, one quarter of which will become fully vested and exercisable on March 19, 2021, with the remaining 150,000 shares vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.